More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY

OBJECTIVE: To report the final long-term safety and efficacy analyses of patients with acromegaly treated with pegvisomant from the ACROSTUDY. DESIGN: Global (15 countries), multicentre, non-interventional study (2004–2017). METHODS: The complete ACROSTUDY cohort comprised patients with acromegaly,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Führer-Sakel, Dagmar, van der Lely, Aart J, De Marinis, Laura, Brue, Thierry, van der Lans-Bussemaker, Joli, Hey-Hadavi, Judith, Camacho-Hubner, Cecilia, Wajnrajch, Michael P, Valluri, Srinivas Rao, Palladino, Andrew Anthony, Gomez, Roy, Salvatori, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428076/
https://www.ncbi.nlm.nih.gov/pubmed/34342594
http://dx.doi.org/10.1530/EJE-21-0239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428076/
https://www.ncbi.nlm.nih.gov/pubmed/34342594
http://dx.doi.org/10.1530/EJE-21-0239

Ejemplares similares